Finanzwire Finanzwire
Basculer en Français
9629 Companies
191456 Keywords
122915 Articles
102031 Press releases
Headlines Articles Press releases ActiTrexx GmbH Remove
  1. Home
  2. Companies
  3. ActiTrexx GmbH
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 10/20/2025 at 10:05, 2 months 22 days ago

    ActiTrexx Completes Final Patient Treatment in GvHD Therapy Study

    Clinical Study Graft-versus-Host Disease Actileucel Immune Therapy Regulatory T Cells
  • PRESS RELEASE

    published on 10/20/2025 at 10:00, 2 months 22 days ago

    ActiTrexx completes treatment of last patient with novel regulatory T cell therapy against Graft-versus-Host Disease

    ActiTrexx completes treatment of last patient with novel regulatory T cell therapy against Graft-versus-Host Disease. Phase Ib/II study evaluates Actileucel for GvHD prevention
    ActiTrexx Graft-versus-Host Disease Regulatory T Cell Therapy Actileucel Phase Ib/II Study
    Logo of ActiTrexx GmbH
  • BRIEF

    published on 03/19/2024 at 10:05, 1 year 9 months ago

    ActiTrexx Initiates Treatment in Graft-versus-Host Disease Study with Novel T Cell Therapy

    Clinical Study ActiTrexx Graft-versus-Host Disease Regulatory T Cell Therapy Actileucel
  • PRESS RELEASE

    published on 03/19/2024 at 10:00, 1 year 9 months ago

    ActiTrexx treats first patient with novel regulatory T cell therapy against Graft-versus-Host Disease

    ActiTrexx GmbH treats first patient with novel regulatory T cell therapy for Graft-versus-Host Disease. Phase Ib/II study evaluates safety and feasibility of Actileucel treatment
    Graft-versus-Host Disease Regulatory T Cell Therapy Actileucel ActiTrexx GmbH Phase Ib/II Study
    Logo of ActiTrexx GmbH
Accesswire
  • Published on 01/10/2026 at 05:10, 1 day 14 hours ago

    Sekur Private Data Ltd. Announces Non-Brokered Private Placement

  • Published on 01/10/2026 at 00:45, 1 day 19 hours ago

    Digi Power X Announces Entry into Settlement Agreement

  • Published on 01/09/2026 at 23:30, 1 day 20 hours ago

    Sun Peak Metals Grants Stock Options

  • Published on 01/09/2026 at 23:30, 1 day 20 hours ago

    Matador Technologies Announces Grant of Restricted Share Units to Management Team

  • Published on 01/09/2026 at 23:10, 1 day 20 hours ago

    Usha Resources and Totec Resources Provide Supplemental Disclosure for Qualifying Transaction

View all ACCESSWIRE
EQS Group
  • Published on 01/10/2026 at 21:25, 22 hours 40 minutes ago

    CATL Opens Middle East's Largest New Energy Aftermarket Facility in Riyadh

  • Published on 01/10/2026 at 13:05, 1 day 7 hours ago

    SeaVerse Launches World's First AI Native Platform, "All in AI Native" Leads the Forward-Looking Revolution in AI Creation

  • Published on 01/09/2026 at 21:55, 1 day 22 hours ago

    Piramal Pharma Achieves Notable Score Increase on 2025 S&P Global Corporate Sustainability Assessment (CSA)

  • Published on 01/09/2026 at 18:36, 2 days 1 hour ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 01/09/2026 at 18:19, 2 days 1 hour ago

    EQS-Adhoc: BayWa AG: Change in the Board of Management of BayWa AG

View all EQS
Les Echos
  • Published on 01/09/2026 at 18:30, 2 days 1 hour ago

    H2 2025 half yearly report on the liquidity agreement signed with the Gilbert Dupont brokerage firm

  • Published on 01/09/2026 at 17:45, 2 days 2 hours ago

    January 2026

  • Published on 01/09/2026 at 17:45, 2 days 2 hours ago

    MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

  • Published on 01/09/2026 at 17:42, 2 days 2 hours ago

    Aéroports de Paris SA - Shares and voting rights as of 31 December 2025

  • Published on 01/08/2026 at 21:00, 2 days 23 hours ago

    Biannual report on SEB S.A.’S liquidity agreement

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy